XML 38 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplementary Information
 12 Months Ended
Dec. 31, 2023
Supplementary Information [Abstract]  
Additional Financial Information Disclosure [Text Block] SUPPLEMENTARY INFORMATION
Other Income (Expense) - NetFor the Year Ended December 31,
(In millions)202320222021
Interest income$283 $124 $77 
Equity in earnings (losses) of affiliates - net10 20 14 
Net gain (loss) on sales of businesses and other assets1
22 18 21 
Net exchange gains (losses)2
(397)(229)(54)
Non-operating pension and other post-employment benefit credits (costs)3
(119)163 1,318 
Miscellaneous income (expenses) - net4
(247)(156)(28)
Other income (expense) - net$(448)$(60)$1,348 
1.    The years ended December 31, 2022 and 2021 include a gain of $15 million and $19 million, respectively, relating to the sale of a business in the crop protection segment.
2.    Includes net pre-tax exchange gains (losses) of $(284) million, $(110) million and $(67) million associated with the devaluation of the Argentine peso for the years ended December 31, 2023, 2022 and 2021, respectively.
3.    Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 
4.    Includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The years ended December 31, 2023, 2022, and 2021 also includes an Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”). The years ended December 31, 2023 and 2022 also includes estimated settlement reserves and gains (losses) associated with the sale of businesses, assets and equity investments. The year ended December 31, 2022 also includes legal accruals and settlement cost associated with the Russia Exit. The year ended December 31, 2021 also includes a charge related to a contract termination with a third-party service provider, a gain from the remeasurement of an equity investment and an officer indemnification payment. See Note 23 - Segment Information, to the Consolidated Financial Statements, for additional information on significant items.

The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States (U.S.), whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income (expense) - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the Consolidated Statements of Operations.
For the Year Ended December 31,
(In millions)202320222021
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gain (loss) $(371)$(217)$(72)
Local tax (expenses) benefits 55 (10)(30)
Net after-tax impact from subsidiary exchange gain (loss) $(316)$(227)$(102)
Hedging Program Gain (Loss)
Pre-tax exchange gain (loss)$(26)$(12)$18 
Tax (expenses) benefits7 5 (4)
Net after-tax impact from hedging program exchange gain (loss) $(19)$(7)$14 
Total Exchange Gain (Loss)
Pre-tax exchange gain (loss) $(397)$(229)$(54)
Tax (expenses) benefits62 (5)(34)
Net after-tax exchange gain (loss) $(335)$(234)$(88)
Cash, cash equivalents and restricted cash equivalents
The following table provides a reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows. Corteva classifies restricted cash equivalents as current or noncurrent based on the nature of the restrictions, which are included in other current assets and other assets, respectively, in the Consolidated Balance Sheets.
(In millions)December 31, 2023December 31, 2022
Cash and cash equivalents$2,644 $3,191 
Restricted cash equivalents514 427 
Total cash, cash equivalents and restricted cash equivalents$3,158 $3,618 

Restricted cash equivalents primarily relates to a trust funded by EIDP for cash obligations under certain non-qualified benefit and deferred compensation plans due to the Merger, which was a change in control event, and contributions to escrow accounts established for the settlement of certain legal matters and the settlement of legacy PFAS matters and the associated qualified spend. All of the company's restricted cash equivalents are classified as current as of December 31, 2023 and 2022, except for the contributions to the escrow account established for the settlement of legacy PFAS matters and the associated qualified spend, which was classified as noncurrent at December 31, 2022.

Accounts payable
Accounts payable was $4,280 million and $4,895 million at December 31, 2023 and 2022, respectively. Accounts payable - trade, which is a component of accounts payable, was $2,952 million and $3,717 million at December 31, 2023 and 2022, respectively. Included in accounts payable – trade was seed grower compensation of approximately $560 million and $470 million at December 31, 2023 and 2022, respectively, which is measured at fair value using level 2 inputs for each period presented. Accrued discounts and rebates, which is a component of accounts payable, was approximately $1,170 million and $1,030 million at December 31, 2023 and 2022, respectively. No other components of accounts payable were more than 5 percent of total current liabilities.